An Open-label, Multi-centre, Phase III Study of Local Tolerability of Zomacton 10 mg (Recombinant Somatropin) administered by ZomaJet Vision X

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001539-31

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the local tolerability of an individualised dose of Zomacton 10 mg administered by ZomaJet Vision X


Critère d'inclusion

  • Zomacton is indicated for the long term treatment of children who have growth failure due to inadequate secretion of growth hormone and for the long-term treatment of growth retardation due to Turner’s Syndrome confirmed by chromosome analysis

Liens